Lv41
650 积分 2025-07-02 加入
Gut Microbiota as the Potential Mechanism to Mediate Drug Metabolism UnderHigh-altitude Hypoxia
2天前
已完结
Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2
3个月前
已完结
Downregulation of Hepatic Cytochrome P450 in Chronic Renal Failure
3个月前
已完结
Age-dependent pharmacokinetics of nifedipine in spontaneous hypertensive rats are associated with changes in gut microbiota and hepatic CYP3A1 expression
4个月前
已关闭
Pharmacokinetics of rosuvastatin in patients with end-stage kidney disease undergoing peritoneal dialysis
4个月前
已完结
Acute Effects of High-Dose Furosemide on Residual Renal Function in CAPD Patients
4个月前
已完结
Antibiotic-induced neurological adverse drug reactions
4个月前
已关闭
Acute Effects of High-Dose Furosemide on Residual Renal Function in CAPD Patients
5个月前
已完结
FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model‐Based Assessments
8个月前
已完结
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry Perspective
8个月前
已完结
皖公网安备34019202002308
